These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 38280033)
1. Expression of molecular markers and synergistic anticancer effects of chemotherapy with antimicrobial peptides on glioblastoma cells. Chernov AN; Kim AV; Skliar SS; Fedorov EV; Tsapieva AN; Filatenkova TA; Chutko AL; Matsko MV; Galimova ES; Shamova OV Cancer Chemother Pharmacol; 2024 May; 93(5):455-469. PubMed ID: 38280033 [TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of the Cytotoxic Effect of Chernov AN; Tsapieva A; Alaverdian DA; Filatenkova TA; Galimova ES; Suvorova M; Shamova OV; Suvorov AN Molecules; 2022 Jan; 27(2):. PubMed ID: 35056889 [TBL] [Abstract][Full Text] [Related]
3. Nerve Growth Factor, Antimicrobial Peptides and Chemotherapy: Glioblastoma Combination Therapy to Improve Their Efficacy. Chernov A; Kudryavtsev I; Komlev A; Alaverdian D; Tsapieva A; Galimova E; Shamova O Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38002009 [TBL] [Abstract][Full Text] [Related]
4. Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells. Chernov AN; Filatenkova TA; Glushakov RI; Buntovskaya AS; Alaverdian DA; Tsapieva AN; Kim AV; Fedorov EV; Skliar SS; Matsko MV; Galimova ES; Shamova OV Molecules; 2022 Aug; 27(15):. PubMed ID: 35956937 [TBL] [Abstract][Full Text] [Related]
5. Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway. Bi Y; Li H; Yi D; Sun Y; Bai Y; Zhong S; Song Y; Zhao G; Chen Y Mol Pharm; 2018 Nov; 15(11):4912-4925. PubMed ID: 30336060 [TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Multiforme: Sensitivity to Antimicrobial Peptides LL-37 and PG-1, and Their Combination with Chemotherapy for Predicting the Overall Survival of Patients. Chernov AN; Skliar SS; Kim AV; Tsapieva A; Pyurveev SS; Filatenkova TA; Matsko MV; Ivanov SD; Shamova OV; Suvorov AN Pharmaceutics; 2024 Sep; 16(9):. PubMed ID: 39339270 [No Abstract] [Full Text] [Related]
7. Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme. Li Z; Zhang J; Zheng H; Li C; Xiong J; Wang W; Bao H; Jin H; Liang P J Exp Clin Cancer Res; 2019 Aug; 38(1):380. PubMed ID: 31462285 [TBL] [Abstract][Full Text] [Related]
8. Methadone-mediated sensitization of glioblastoma cells is drug and cell line dependent. Haas B; Ciftcioglu J; Jermar S; Weickhardt S; Eckstein N; Kaina B J Cancer Res Clin Oncol; 2021 Mar; 147(3):779-792. PubMed ID: 33315125 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological inhibition of serine synthesis enhances temozolomide efficacy by decreasing O Jin L; Kiang KM; Cheng SY; Leung GK Lab Invest; 2022 Feb; 102(2):194-203. PubMed ID: 34625658 [TBL] [Abstract][Full Text] [Related]
10. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068 [TBL] [Abstract][Full Text] [Related]
11. Effect of lomeguatrib-temozolomide combination on MGMT promoter methylation and expression in primary glioblastoma tumor cells. Taspinar M; Ilgaz S; Ozdemir M; Ozkan T; Oztuna D; Canpinar H; Rey JA; Sunguroğlu A; Castresana JS; Ugur HC Tumour Biol; 2013 Jun; 34(3):1935-47. PubMed ID: 23519841 [TBL] [Abstract][Full Text] [Related]
12. The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells. Atif F; Patel NR; Yousuf S; Stein DG PLoS One; 2015; 10(6):e0131441. PubMed ID: 26110872 [TBL] [Abstract][Full Text] [Related]
13. Temozolomide treatment combined with AZD3463 shows synergistic effect in glioblastoma cells. Goker Bagca B; Ozates NP; Asik A; Caglar HO; Gunduz C; Biray Avci C Biochem Biophys Res Commun; 2020 Dec; 533(4):1497-1504. PubMed ID: 33109342 [TBL] [Abstract][Full Text] [Related]
14. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of NF-κB results in anti-glioma activity and reduces temozolomide-induced chemoresistance by down-regulating MGMT gene expression. Yu Z; Chen Y; Wang S; Li P; Zhou G; Yuan Y Cancer Lett; 2018 Aug; 428():77-89. PubMed ID: 29705182 [TBL] [Abstract][Full Text] [Related]
16. Intranasal Delivery of Temozolomide-Conjugated Gold Nanoparticles Functionalized with Anti-EphA3 for Glioblastoma Targeting. Wang L; Tang S; Yu Y; Lv Y; Wang A; Yan X; Li N; Sha C; Sun K; Li Y Mol Pharm; 2021 Mar; 18(3):915-927. PubMed ID: 33417456 [TBL] [Abstract][Full Text] [Related]
18. Combination of levetiracetam and IFN-α increased temozolomide efficacy in MGMT-positive glioma. Ni XR; Guo CC; Yu YJ; Yu ZH; Cai HP; Wu WC; Ma JX; Chen FR; Wang J; Chen ZP Cancer Chemother Pharmacol; 2020 Dec; 86(6):773-782. PubMed ID: 33074386 [TBL] [Abstract][Full Text] [Related]
19. Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition. Liu T; Li A; Xu Y; Xin Y Oncol Rep; 2019 Mar; 41(3):1883-1892. PubMed ID: 30664175 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of EGFR plus TNF inhibition in a preclinical model of temozolomide-resistant glioblastoma. Guo G; Gong K; Puliyappadamba VT; Panchani N; Pan E; Mukherjee B; Damanwalla Z; Bharia S; Hatanpaa KJ; Gerber DE; Mickey BE; Patel TR; Sarkaria JN; Zhao D; Burma S; Habib AA Neuro Oncol; 2019 Dec; 21(12):1529-1539. PubMed ID: 31363754 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]